Growth Metrics

Merck (MRK) Long-Term Deferred Tax (2016 - 2023)

Merck has reported Long-Term Deferred Tax over the past 14 years, most recently at $10.2 billion for Q2 2023.

  • Quarterly Long-Term Deferred Tax fell 7.15% to $10.2 billion in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $10.2 billion through Jun 2023, down 7.15% year-over-year, with the annual reading at $9.5 billion for FY2022, 17.73% down from the prior year.
  • Long-Term Deferred Tax was $10.2 billion for Q2 2023 at Merck, down from $10.3 billion in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $11.6 billion in Q4 2021 and troughed at $6.8 billion in Q4 2019.
  • The 5-year median for Long-Term Deferred Tax is $9.7 billion (2020), against an average of $9.6 billion.
  • Year-over-year, Long-Term Deferred Tax decreased 19.01% in 2020 and then surged 48.7% in 2021.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $6.8 billion in 2019, then soared by 45.93% to $9.9 billion in 2020, then rose by 17.21% to $11.6 billion in 2021, then decreased by 17.73% to $9.5 billion in 2022, then increased by 6.92% to $10.2 billion in 2023.
  • Per Business Quant, the three most recent readings for MRK's Long-Term Deferred Tax are $10.2 billion (Q2 2023), $10.3 billion (Q1 2023), and $9.5 billion (Q4 2022).